
October 2026
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder. | $13 | -28% | $11B | $14B | 2.3x | 9.4x | |||
Renishaw Plc is an engineering company specializing in precision measurement and healthcare technologies. It operates in two reporting segments: Manufacturing technologies, and Analytical instruments and medical devices. Its products include coordinate measuring machines, machine tool probes, metal 3D printers, neurosurgical systems, and dental technologies. The company generates the majority of its revenue from exporting these products to the markets in countries like China, the USA, Japan, and Germany. Renishaw has operations in several countries and focuses on research, development, and manufacturing prominently in the UK, Ireland, and India. The company serves diverse industrial and healthcare sectors. | $78 | +67% | $5.6B | $5.3B | 5.6x | 27.7x | |||
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue. | $3 | -10% | $5.5B | $7.2B | 2.9x | 14.0x | |||
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC. | $3 | +62% | $2.9B | $2.7B | 9.0x | (20.3x) | |||
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. | $12 | +83% | $1.6B | $1.2B | - | (4.2x) | |||
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom. | $11 | -5% | $1.5B | $3.9B | 1.1x | 9.5x | |||
Advanced Medical Solutions Group PLC is engaged in developing, and manufacturing advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical; and Woundcare, of which Surgical segment derives maximum revenue. | $4 | +32% | $813M | $910M | 3.0x | 15.7x | |||
The Beauty Tech Group PLC operates in the at-home beauty technology market. It offers beauty treatment devices designed for home use, incorporating technologies such as LED light, radiofrequency, microcurrent, and laser-based treatments. The products are offered through CurrentBody Skin, ZIIP Beauty, and Tria Laser brands. The company distributes its products through direct-to-consumer e-commerce channels and selected retail partners. Its operating segments are: CurrentBody Skin, ZIIP Beauty, Tria Laser, and Third-Party. Maximum revenue is derived from the CurrentBody Skin segment, which offers LED masks, radio-frequency devices, and facial-cleansing tools. Geographically, it generates maximum revenue from the USA, and the rest from UK, Asia, the rest of Europe, and the rest of the world. | $6 | +78% | $658M | $595M | 3.2x | 16.2x | |||
Craneware PLC provides automated revenue integrity solutions that improve financial performance for healthcare organizations. Its activities include the development, licensing, and ongoing support of computer software for the US healthcare industry. It is engaged in the sale of software licenses, white labelling, and professional services (including installation) to hospitals within the USA. The company recognizes its revenues from the sale of and distribution agreements relating to software licenses and professional services. | $14 | -53% | $474M | $465M | 2.3x | 7.8x | |||
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world. | $1 | -1% | $376M | $354M | 5.5x | 18.0x | |||
Optima Health PLC is a provider of technology-enabled corporate health and wellbeing solutions in the occupational health sector. The group offers a comprehensive range of flexible and progressive services, from statutory-driven workplace health surveillance medicals to proactive and preventive interventions, as well as workplace health advice and attendance management assessments. These services are ultimately rehabilitation programs and pathways designed to help people return to work. | $3 | +23% | $347M | $484M | 3.0x | 24.0x | |||
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements. | $0 | -8% | $137M | $122M | 1.8x | 7.5x | |||
TeraView Holdings PLC is a holding company. It provides specialized solutions for semiconductor packaging, automotive painting and high-value-added coating, and lithium-ion batteries, leveraging non-destructive testing and measurement technology utilizing terahertz (THz) frequencies. The company offers customized solutions for each industry based on its accumulated technological prowess and is expanding into various markets. Its product offerings include EOTPR, TeraCota 3000, TeraCota 3500, and TeraPulse. The maximum revenue is being generated from EOTPR (Electro-Optical Terahertz Pulse Reflectometry), which is a solution for non-destructively diagnosing various defects occurring in the semiconductor packaging process. | $3 | -- | $112M | $63M | 3.6x | - | |||
Kooth PLC is a digital mental health provider to the NHS for children and young people by providing a broad range of therapeutic tools and interventions. The company's online platform provides Self-help tools and content, Community for Peer-to-Peer Support and Professional Counselling. It provides individuals with free access to mental health support, funded by healthcare systems, insurers, businesses or charities. The company's operations take place in the UK and the United States. | $2 | +39% | $88M | $57M | 0.7x | 4.4x | |||
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on wellness management through a non-clinical platform. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. | $0 | -1% | $81M | $82M | - | (15.4x) | |||
Vulcan Two Group PLC is a new company that has been established to acquire companies or businesses that have the potential to generate shareholder value. It will focus on acquiring companies in the ePharmacy market and will initially focus on businesses operating substantially in the UK. | $3 | -15% | $74M | $69M | |||||
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world. | $0 | -11% | $59M | $55M | |||||
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease. Its product, KidneyIntelX, is designed to improve kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company's service, KidneyIntelX.dkd, enables the assessment of risk for early-stage chronic kidney disease progression. KidneyIntelX uses a proprietary algorithm combining blood-based biomarkers, inherited genetics, and electronic health record data to generate a patient risk score predicting rapid kidney function decline. | $0 | -21% | $53M | $53M | |||||
EDX Medical Group PLC is principally engaged in the business of creating health testing solutions and developing biological and digital technologies to improve the detection of diseases and disorders. It develops and provides digital diagnostic products and services for testing in areas including cancer, cardiovascular disease, neurology, and infectious diseases. It operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development, and provides testing and genomic sequencing services. It has two operating segments: Medical goods and Medical services. The majority of revenue is generated from the Medical goods segment. Geographically, all revenue was derived from the United Kingdom. | $0 | -- | $50M | $46M | |||||
Doctor Care Anywhere Group PLC is a telehealth company that provides clinical care through digitally enabled, joined-up, evidence-based pathways on its proprietary platform. It utilizes its relationships with health insurers, healthcare providers, and corporate customers to connect with patients to deliver a range of telehealth services. The Group provides virtual healthcare services, technology platform licensing, and digital design services, within the United Kingdom, Australia, and the Republic of Ireland. The company derives a majority of its revenue from the UK and Ireland. | $0 | -15% | $33M | $36M | |||||
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom and also has its presence in Europe, United States of America and Rest of the World. | $0 | +13% | $25M | $25M | |||||
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the precise measurement of clinical outcomes in neurological disorders. Geographically, it derives majority of its revenue from the United States of America and also has a presence in the United Kingdom, European Union, and Rest of world. The company services include Neuroscience consultancy, Technical consultancy, Study design, Data analysis, Study management, Data management, and Reports and interpretation. | $0 | -17% | $20M | $20M | |||||
Physitrack PLC is a digital healthcare provider, focused on physiotherapy and musculoskeletal care market. The company operates in two business lines namely Lifecare and Wellness. The Lifecare segment is the provision of Lifecare platforms tailored to physiotherapy being made up of the Physitrack PLC, Physiotools OY and Mobilus Digital Rehab AB Physiotools businesses. The Wellness segment relates to the provision of Wellness services including digital platforms to both corporates and individuals. Geographically, the company has its presence in United Kingdom, Europe, North America and Rest of World. | $1 | -38% | $16M | $20M | |||||
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making, and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. Its operating segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa, a regulated communication platform for sharing clinical results and supporting multidisciplinary teamwork, and CareLocker, a patient-facing platform that provides access and control over diagnostic and clinical data. | $0 | -31% | $4M | - | |||||
| Median | $3 | -7% | $124M | $122M | 3.0x | 5.3x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.